Open Access
Colon cancer stem cells: implications in carcinogenesis
Matthew A Sanders1,Adhip P N Majumdar1
Karmanos Cancer Institute, Wayne State University, Detroit, MI 48201, USA
DOI: 10.2741/3811 Volume 16 Issue 5, pp.1651-1662
Published: 01 January 2011
(This article belongs to the Special Issue Novel strategies for detection, prevention and treatment of cancer)

The cancer stem cell model was described for hematologic malignancies in 1997 and since then evidence has emerged to support it for many solid tumors as well, including colon cancer. This model proposes that certain cells within the tumor mass are pluripotent and capable of self-renewal and have an enhanced ability to initiate distant metastasis. The cancer stem cell model has important implications for cancer treatment, since most current therapies target actively proliferating cells and may not be effective against the cancer stem cells that are responsible for recurrence. In recent years great progress has been made in identifying markers of both normal and malignant colon stem cells. Proteins proposed as colon cancer stem cell markers include CD133, CD44, CD166, ALDH1A1, Lgr5, and several others. In this review we consider the evidence for these proteins as colon cancer stem cell markers and as prognostic indicators of colon cancer survival. Additionally, we discuss potential functions of these proteins and the implications this may have for development of therapies that target colon cancer stem cells.

Share and Cite
Matthew A Sanders, Adhip P N Majumdar. Colon cancer stem cells: implications in carcinogenesis. Frontiers in Bioscience-Landmark. 2011. 16(5); 1651-1662.